QUALITATIVE AND QUANTITATIVE MINIMAL DISEASE MEASUREMENT IN ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: EFFICACY OF INTERNATIONAL QUALITY CONTROL AND EVENT-FREE SURVIVAL ACCORDING TO DIFFERENT MINIMAL DISSEMINATED DISEASE CUT-OFFS

IF 2.2 4区医学 Q3 HEMATOLOGY

Leukemia research Pub Date : 2025-09-01 DOI:10.1016/j.leukres.2025.107977

Christine Damm-Welk, Cathy Quelen, Laurence Lamant, Gaia Martire, Lukas Duscher, Reiji Fukano, Yuka Iijima-Yamashita, Itziar Sallevaria, Julia Salmeron-Villalobos, Liz Yuet-Ping Yuen, Yu-Kwan Tong, Suzanne D. Turner, Rogier ten Hoopen, Edwin Sonneveld, Eric Strengman, Maria Hansen, Guy Wayne Novotny, Megan S. Lim, Rui Wu, Ariel Long, Lara Mussolin

引用次数: 0

查看原文本刊更多论文

alk阳性间变性大细胞淋巴瘤的定性和定量最小疾病测量：根据不同最小弥散性疾病临界值的国际质量控制和无事件生存的疗效

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Leukemia research 医学-血液学

CiteScore

4.00

自引率

3.70%

发文量

259

审稿时长

1 months

期刊介绍： Leukemia Research an international journal which brings comprehensive and current information to all health care professionals involved in basic and applied clinical research in hematological malignancies. The editors encourage the submission of articles relevant to hematological malignancies. The Journal scope includes reporting studies of cellular and molecular biology, genetics, immunology, epidemiology, clinical evaluation, and therapy of these diseases.